Literature DB >> 17435482

Measuring anxiety in patients with schizophrenia.

Soraya Seedat1, Vega Fritelli, Piet Oosthuizen, Robin A Emsley, Dan J Stein.   

Abstract

This study describes the prevalence and distribution of anxiety symptomatology and anxiety disorders in a sample of hospitalized patients with schizophrenia, the estimated level of agreement between a clinician diagnostic measure and anxiety symptom status measures, and their internal consistency based on the average interitem correlations. Seventy inpatients receiving treatment for schizophrenia were assessed before discharge using a face-to-face diagnostic interview and structured questionnaires, namely the Mini International Neuropsychiatric Interview, the Hospital Anxiety and Depression Scale, the Hamilton Anxiety Scale, the Spielberger Anxiety Inventory, and the Stein Generalized Anxiety Disorder (GAD) Scale. About a quarter of patients met criteria for an anxiety disorder, with GAD and social phobia occurring most commonly. There was poor agreement between the Mini International Neuropsychiatric Interview and a diagnosis of anxiety based on symptom status measures. The Stein GAD scale demonstrated the highest internal consistency (0.85) followed by the Hamilton Anxiety Scale (0.76). Anxiety disorders and anxiety symptomatology are highly prevalent in schizophrenia. Accurate assessment is challenging yet important. More reliable measures of anxiety disorders in patients with schizophrenia and other psychotic disorders are clearly needed to allow for timely identification and treatment.

Entities:  

Mesh:

Year:  2007        PMID: 17435482     DOI: 10.1097/01.nmd.0000253782.47140.ac

Source DB:  PubMed          Journal:  J Nerv Ment Dis        ISSN: 0022-3018            Impact factor:   2.254


  15 in total

1.  ΔFosB induction in prefrontal cortex by antipsychotic drugs is associated with negative behavioral outcomes.

Authors:  David M Dietz; Pamela J Kennedy; Haosheng Sun; Ian Maze; Amy M Gancarz; Vincent Vialou; Ja Wook Koo; Ezekiell Mouzon; Subroto Ghose; Carol A Tamminga; Eric J Nestler
Journal:  Neuropsychopharmacology       Date:  2013-09-26       Impact factor: 7.853

Review 2.  Anxiety in Patients with Schizophrenia: Epidemiology and Management.

Authors:  Henk Temmingh; Dan J Stein
Journal:  CNS Drugs       Date:  2015       Impact factor: 5.749

Review 3.  How prevalent are anxiety disorders in schizophrenia? A meta-analysis and critical review on a significant association.

Authors:  Amélie M Achim; Michel Maziade; Eric Raymond; David Olivier; Chantal Mérette; Marc-André Roy
Journal:  Schizophr Bull       Date:  2009-12-03       Impact factor: 9.306

4.  A Retrospective Study of the Clinical Characteristics Associated with Alcohol and Cannabis use in Early Phase Psychosis.

Authors:  Jacob Cookey; Jacob McGavin; Candice E Crocker; Kara Matheson; Sherry H Stewart; Philip G Tibbo
Journal:  Can J Psychiatry       Date:  2020-02-04       Impact factor: 4.356

5.  Anxiety interacts with expressed emotion criticism in the prediction of psychotic symptom exacerbation.

Authors:  Nancy M Docherty; Annie St-Hilaire; Jennifer M Aakre; James P Seghers; Amanda McCleery; Marielle Divilbiss
Journal:  Schizophr Bull       Date:  2009-11-05       Impact factor: 9.306

Review 6.  Psychiatric comorbidities and schizophrenia.

Authors:  Peter F Buckley; Brian J Miller; Douglas S Lehrer; David J Castle
Journal:  Schizophr Bull       Date:  2008-11-14       Impact factor: 9.306

7.  The postweaning social isolation in C57BL/6 mice: preferential vulnerability in the male sex.

Authors:  Susanna Pietropaolo; Philipp Singer; Joram Feldon; Benjamin K Yee
Journal:  Psychopharmacology (Berl)       Date:  2008-03-04       Impact factor: 4.530

8.  A comprehensive model of predictors of quality of life in older adults with schizophrenia: results from the CSA study.

Authors:  Nicolas Hoertel; Léa Rotenberg; Carlos Blanco; Vincent Camus; Caroline Dubertret; Véronique Charlot; Franck Schürhoff; Pierre Vandel; Frédéric Limosin
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2020-05-15       Impact factor: 4.328

9.  Chronic Adolescent Δ9-Tetrahydrocannabinol Treatment of Male Mice Leads to Long-Term Cognitive and Behavioral Dysfunction, Which Are Prevented by Concurrent Cannabidiol Treatment.

Authors:  Michelle Murphy; Sierra Mills; Joanna Winstone; Emma Leishman; Jim Wager-Miller; Heather Bradshaw; Ken Mackie
Journal:  Cannabis Cannabinoid Res       Date:  2017-09-01

10.  Better Sleep in a Strange Bed? Sleep Quality in South African Women with Posttraumatic Stress Disorder.

Authors:  Gosia Lipinska; Kevin G F Thomas
Journal:  Front Psychol       Date:  2017-09-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.